Anne-Sophie Defachelles

23PUBLICATIONS
117CO-AUTHORS
Gene and molecular therapyHaematological tumoursPredictive and prognostic markersAutonomic nervous systemCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 15, 2026
Real-World Use of Dinutuximab Beta for High-Risk Neuroblastoma in Clinical Settings in France: The QUATUOR Study.

|Dec 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.

Juliet C Gray, Rebekah Weston, Cormac Owens

|Oct 16, 2025
Childhood, Adolescent and Young Adult Poor-Prognosis Rhabdomyosarcoma.

Ajla T Wasti, Gianni Bisogno, Raquel Hladun

|Oct 04, 2025
Chemo-Immunotherapy Rescue for High-Risk Neuroblastoma Patients With Progressive Disease Before High-Dose Chemotherapy: Real-World Data From the SACHA-France Study.

Claudia Pasqualini, Stéphanie Proust, Gudrun Schleiermacher

|Sep 05, 2025
Relapsed rhabdomyosarcoma: treatment recommendations from the European pediatric soft tissue sarcoma study group (EpSSG).

A S Defachelles, W B Breunis, M Casanova

|Sep 04, 2025
Atypical Neuroblastoma With Absent Urinary Catecholamine Excretion and 123ImIBG Avidity Are of Favorable Outcome: A Retrospective French Single-Center Study.

Anna Borovkov, Juliette Assy, Isabelle Aerts

Pageof 4

Frequent Collaborators

7 joint publications

Daniel Orbach

6 joint publications

Gianni Bisogno

5 joint publications

Julia Chisholm

5 joint publications

Johannes Hendrikus Maria Merks